SEC 13F Intelligence

Skandinaviska Enskilda Banken AB (Publ) / BSX

Skandinaviska Enskilda Banken AB (Publ)’s Boston Scientific Corp Position

Does Skandinaviska Enskilda Banken AB (Publ) own Boston Scientific Corp (BSX)? Yes — 387.3K shares worth $24M (+0.56% of its 13F portfolio) as of Q1 2026, down from 2.84M shares the prior filed quarter.

Position Value
$24M
Q1 2026
Shares
387.3K
% of Portfolio
+0.56%
Quarters Held
30
currently held

Position History BSX

Reported value by quarter
Q4 ’18: $9MQ4 ’18Q1 ’19: $10MQ2 ’19: $12MQ3 ’19: $11MQ4 ’19: $14MQ4 ’19Q1 ’20: $10MQ2 ’20: $10MQ3 ’20: $13MQ4 ’20: $12MQ4 ’20Q1 ’21: $13MQ2 ’21: $16MQ3 ’21: $75MQ4 ’21: $14MQ4 ’21Q1 ’22: $41MQ2 ’22: $41MQ3 ’22: $41MQ4 ’22: $52,227Q4 ’22Q1 ’23: $53,279Q2 ’23: $58,678Q3 ’23: $56,929Q4 ’23: $66MQ4 ’23Q1 ’24: $77MQ2 ’24: $72MQ3 ’24: $79MQ4 ’24: $84MQ4 ’24Q1 ’25: $137MQ2 ’25: $218MQ3 ’25: $249MQ4 ’25: $270MQ4 ’25Q1 ’26: $24Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026387.3K$24M+0.56%
Q4 20252.84M$270M+1.08%
Q3 20252.55M$249M+1.00%
Q2 20252.03M$218M+0.95%
Q1 20251.36M$137M+0.68%
Q4 2024940.8K$84M+0.38%
Q3 2024945.4K$79M+0.37%
Q2 2024931.7K$72M+0.34%
Q1 20241.12M$77M+0.37%
Q4 20231.14M$66M+0.38%
Q3 20231.08M$56,929+0.37%
Q2 20231.08M$58,678+0.38%
Q1 20231.06M$53,279+0.37%
Q4 20221.13M$52,227+0.39%
Q3 20221.07M$41M+0.32%
Q2 20221.09M$41M+0.30%
Q1 2022924.0K$41M+0.24%
Q4 2021327.0K$14M+0.07%
Q3 20211.73M$75M+0.41%
Q2 2021366.3K$16M+0.10%
Q1 2021340.9K$13M+0.09%
Q4 2020337.4K$12M+0.08%
Q3 2020338.5K$13M+0.09%
Q2 2020288.4K$10M+0.08%
Q1 2020320.6K$10M+0.11%
Q4 2019305.3K$14M+0.11%
Q3 2019268.1K$11M+0.09%
Q2 2019268.6K$12M+0.10%
Q1 2019251.6K$10M+0.09%
Q4 2018250.7K$9M+0.08%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Skandinaviska Enskilda Banken AB (Publ)’s full portfolio or all institutional holders of BSX.